Full-Time

Stat Programmer 2/ Senior Statistical Programmer

R/R Shiny

Syneos Health

Syneos Health

10,001+ employees

Global provider of integrated clinical-to-commercial services

No salary listed

Remote in India

Remote

Category
Biology & Biotech (1)
Required Skills
R
Git
Requirements
  • 5+ years’ hands on experience in R programming in Clinical domain industry who can create visualizations in R using R Shiny
  • Mastery of basic Git skills in either GitHub or GitLab, including committing, branching, pushing, pulling, merge requests and code review.
  • Mastery of tidyverse for data wrangling and visualizing data using ggplot2.
  • Deep experience using R Shiny.
  • Experience working with clinical trial data
Responsibilities
  • Require 5+ years’ hands on experience in R programming in Clinical domain industry who can create visualizations in R using R Shiny
  • Mastery of basic Git skills in either GitHub or GitLab, including committing, branching, pushing, pulling, merge requests and code review.
  • Mastery of tidyverse for data wrangling and visualizing data using ggplot2.
  • Deep experience using R Shiny.
  • Experience working with clinical trial data
  • study lead experience and capable of managing multiple studies.
  • Good written and verbal communications skills
Desired Qualifications
  • R package development
  • Experience working with AI coding agents, e.g. Claude
  • Iron Python knowledge will be value added along with R programming.

Syneos Health provides end-to-end biopharmaceutical solutions across the clinical-to-commercial spectrum. It helps biopharma companies, healthcare organizations, and investors by offering specialized expertise, insights, and technology-enabled services to move therapies faster to patients. Its offerings include Kinetic, a modern omnichannel customer engagement platform that uses targeting and analytics to coordinate nationwide healthcare communications, and Syneos One, an asset development approach that aligns strategy and execution from early concept through commercialization. The company uses AI and advanced tech to improve performance and reduce risk in drug development and market delivery. Its goal is to be a trusted partner that accelerates therapy development and delivery by combining scientific know-how with integrated, data-driven services.

Company Size

10,001+

Company Stage

IPO

Headquarters

Morrisville, North Carolina

Founded

1985

Simplify Jobs

Simplify's Take

What believers are saying

  • KAI Conversations partnership embeds AI conversation intelligence into commercial solutions since April 2026.
  • Bestudy acquisition secures foothold in China's rapidly growing biopharma market.
  • Sunway Healthcare partnership expands clinical trial expertise across Malaysia's therapeutic areas.

What critics are saying

  • Securities class action advances to discovery after March 2026 court denial in SDNY.
  • Abandoning 2016 NC jobs grant triggers government clawbacks within 6-12 months.
  • China Bestudy acquisition halts trials from CFDA inspections in 12-18 months.

What makes Syneos Health unique

  • Syneos Health integrates clinical, real-world evidence, and commercial strategy for end-to-end biopharma solutions.
  • Kinetic platform delivers AI-powered omnichannel customer engagement for healthcare organizations.
  • Syneos One methodology combines asset strategy and execution from concept to commercialization.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Syneos Health who can refer or advise you

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Company Match

Employee Stock Purchase Plan

Flexible Work Hours

Paid Vacation

Paid Sick Leave

Remote Work Options

Company News

Fierce Biotech
Mar 19th, 2026
Syneos Health scoops up Chinese CRO to secure place in ‘rapidly growing market’

North Carolina-based contract research organization Syneos Health is making a play to capitalize on China’s rapidly ascendant biopharma industry. | North Carolina-based contract research organization Syneos Health is making a play to capitalize on China’s rapidly ascendant biopharma industry. Syneos has acquired Chinese CRO Bestudy to secure a foothold in the Asian nation.

PRWeek
May 7th, 2025
Imre hires Greg Voyles as chief growth officer

Voyles joins Imre from Syneos Health, where he served as VP of commercial solutions.

Healthcare Asia Magazine
Dec 2nd, 2024
Sunway Healthcare Group, Syneos Health to expand clinical trial expertise

Sunway Healthcare Group has partnered with Syneos Health to expand clinical trial capabilities across therapeutic areas in Malaysia.

BioSpace
Oct 10th, 2024
Syneos Health Appoints Costa Panagos as Chief Executive Officer

Syneos Health appoints Costa Panagos as chief executive officer.

PRWeek
Oct 7th, 2024
Syneos Health makes senior hires

Syneos has also appointed Jen Husdan as an associate director.